Spero Therapeutics: The GlaxoSmithKline-Deal Changes Everything And Protects Shareholder Value [Seeking Alpha]
Spero Therapeutics, Inc. (SPRO)
Last spero therapeutics, inc. earnings: 3/16 08:45 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.sperotherapeutics.com/overview
Company Research
Source: Seeking Alpha
alphaspirit/iStock via Getty ImagesSpero Therapeutics (NASDAQ:SPROdealGSKsecures the futurereceived by the market and the share price tripled at its peak within a very short period of time.In my opinion, the example of Spero Therapeutics is a very good example of how irrational biotech stocks are currently valued by the market. On the one hand, the enormous surge in market capitalization shows very clearly how undervalued Spero Therapeutics was before the deal was announced. Ultimately, the value was not created by positive trial data and progress in Spero's clinical development pipeline, but the existing pipeline value was simply validated by an external partner. On the other hand, I think the current price shows that the market is still having difficulties valuing the deal.In the following article, I will analyze whether the share price surge is justified and derive a fair value for Spero.Business of Spero TherapeuticsLogo of Spero Therapeutics(Source: Company Homepage)It is our mis
Show less
Read more
Impact Snapshot
Event Time:
SPRO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SPRO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SPRO alerts
High impacting Spero Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SPRO
News
- Spero Therapeutics Delivers On Game Plan To Create Shareholder Value [Seeking Alpha]Seeking Alpha
- Spero Therapeutics, Inc. (NASDAQ: SPRO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Spero Therapeutics, Inc. (NASDAQ: SPRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.MarketBeat
- Spero Therapeutics, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year [Yahoo! Finance]Yahoo! Finance
- Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
SPRO
Earnings
- 3/13/24 - Beat
SPRO
Sec Filings
- 4/16/24 - Form ARS
- 4/16/24 - Form DEFA14A
- 4/16/24 - Form DEF
- SPRO's page on the SEC website